Stephen Patton, the City of Chicago’s former top lawyer, has returned to practice at Kirkland & Ellis, a firm where he had spent over 30 years as a litigator.
Having begun his legal practice at Kirkland & Ellis’ Chicago office nearly 40 years ago, Stephen Patton has returned to his old firm after spending six years as corporation counsel and senior legal adviser to Chicago’s Mayor Rahm Emanuel and other city commissioners.
Appointed by the mayor in 2011, Patton oversaw the city’s legal department which has over 250 lawyers working on litigation, transactions and enforcing municipal code violations.
Among his work as the city’s top lawyer, in 2014 Patton’s department sued five pharmaceutical majors (Purdue Pharma, Cephalon, Janssen Pharmaceuticals, Endo Health Solutionsand Actavis) for misrepresentations in the marketing of highly addictive opioids. That action led pharmaceutical manufacturer Pfizer, which was not named in the 2014 lawsuit and was not accused of any wrongdoing, to reach a breakthrough agreement with the city whereby it would impose stricter standards for the marketing and promotion of prescription opioids.
Kirkland last year represented Cephalon, which is owned by Israeli drug company Teva Pharmaceuticals, in its USD 125 million settlement with 48 US states for an antitrust suit brought over alleged pay-for-delay conduct. That settlement followed a larger USD 1.2 billion settlement the company reached in 2015 with the Federal Trade Commission.
Aside from Cephlon, of which he will steer clear, Patton says that following a thorough screening process, there are no other overlaps from his very city-specific work and what he will be doing at a Kirkland.
In a firm statement, Kirkland partner Mark Filip said: “Steve is a superb technical lawyer, and he also can counsel clients on all of the related aspects of high-stakes courtroom litigation, including board governance, communications and crisis management,” the latter of which the firm has a dedicated crisis communications and management practice which was formed by New York partner Lauren Casazza.
Full Content: Kirkland & Ellis LLP
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Johnson & Johnson to Acquire Intra-Cellular Therapies in $14.6 Billion Deal
Jan 14, 2025 by
CPI
EU Regulators Reevaluate Big Tech Cases as Trump Prepares to Take Office
Jan 14, 2025 by
CPI
Supreme Court Declines to Hear Realtors’ Appeal, DOJ Antitrust Probe Moves Forward
Jan 13, 2025 by
CPI
Commerzbank Chairman Doubts Amicable Merger with UniCredit After Stake Acquisition
Jan 13, 2025 by
CPI
Senator Warren Presses HUD Nominee on Rent Price-Fixing
Jan 13, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – CRESSE Insights
Dec 19, 2024 by
CPI
Effective Interoperability in Mobile Ecosystems: EU Competition Law Versus Regulation
Dec 19, 2024 by
Giuseppe Colangelo
The Use of Empirical Evidence in Antitrust: Trends, Challenges, and a Path Forward
Dec 19, 2024 by
Eliana Garces
Some Empirical Evidence on the Role of Presumptions and Evidentiary Standards on Antitrust (Under)Enforcement: Is the EC’s New Communication on Art.102 in the Right Direction?
Dec 19, 2024 by
Yannis Katsoulacos
The EC’s Draft Guidelines on the Application of Article 102 TFEU: An Economic Perspective
Dec 19, 2024 by
Benoit Durand